They're mentioned in the first sentence by name...

I'm delighted Laura has driven this momentous effort and am so excited to hear her speak at the event. As someone who often is that token, last minute, diversity invite to a manel, I appreciate the sentiment and there are indeed times for calling this out. But I don't think that's the case here.

Our team at @unibirmingham.bsky.social have supported the UK National Screening Committee in the evidence approach for #AI in Diabetic Eye Screening over last few years.

In this paper we outline the NSC's considerations for evaluating ARIAs in England.

doi.org/10.1016/j.la...

Great to be at NICE Conference yesterday for a closing discussion on AI! Can we ensure evidence generation is as adaptive and intelligent as the technology, without compromising definitions of 'Safe, Effective and Equitable & do it in a way that is collaborative, transparent and trustworthy?

The MHRA has just announced 5 AI products for its Airlock (Regulatory Sandbox) programme. I’m on the governance board and am excited to see this take flight.

The products include:
- two LLM based devices
- a platform
- a personalised care product (breast cancer)
- a risk prediction product (COPD)

Excited to be speaking at #THISspace2024 tomorrow on Responsible data science and health innovation, hosted by @thisinstitute.bsky.social

This MSc is for anyone from a clinical, technical, or operational background. It will prepare you to lead multidisciplinary teams to deliver AI-enabled benefits to patients and services.

Gaps in health #data drives health #inequalities in an #AI and data-driven future. We wrote about this in NEJM AI and are working on it at STANDING Together: www.datadiversity.org

Happy Friday new Bluesky friends, I’m off to hibernate and recharge for the weekend

My talk had one message "AI without monitoring is AI at-risk". We need more NHS system readiness investment. I'm excited that we will start work on defining what organisational AI readiness looks like.

Dr Rishi Das-Gupta, Health Innovation Network: companies finding it harder to 'deploy' (sell) in NHS if it includes the word 'AI', encouraging impact focused assessment, highlighting commercial sustainability as a problem with AI in NHS

Rob Turin, BSI: BS30440 standards were developed for AI validation. Good start when we had nothing to work on, but long term impact of standard - TBD.

Russell Pearson from MHRA - MHRA has published tonnes of guidance already and more to come. Alignment amongst regulators (internationally) important. Do check out AIDRS (UK multi-regulator forum). And #AI Airlock (exciting and important) - sandbox exploring novel regulatory challenges posed by AI .

I’m speaking on safe implementation of #AI and real world monitoring tomorrow - making a case for translational trials and algorithmic audits (and making sure hospitals have the resources to do it)
www.westminsterforumprojects.co.uk/conference/A...